This is a Validated Antibody Database (VAD) review about dogs CD9, based on 18 published articles (read how Labome selects the articles), using CD9 antibody in all methods. It is aimed to help Labome visitors find the most suited CD9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (HI9a)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD9 antibody (BioLegend, HI9a) was used in flow cytometry on human samples (fig s3). J Clin Invest (2019) ncbi
mouse monoclonal (HI9a)
BioLegend CD9 antibody (BioLegend, HI9a) was used . BMC Vet Res (2019) ncbi
mouse monoclonal (HI9a)
  • flow cytometry; human; loading ...; fig s1d
BioLegend CD9 antibody (Biolegend, HI9a) was used in flow cytometry on human samples (fig s1d). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (HI9a)
  • flow cytometry; human; fig 3c
BioLegend CD9 antibody (BioLegend, 312103) was used in flow cytometry on human samples (fig 3c). Cell (2018) ncbi
mouse monoclonal (HI9a)
  • western blot; human; fig 4
In order to describe the extracellular vesicles present in breast milk, BioLegend CD9 antibody (BioLegend, HI9a) was used in western blot on human samples (fig 4). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (HI9a)
  • flow cytometry; human; fig 2
BioLegend CD9 antibody (BioLegend, 312105) was used in flow cytometry on human samples (fig 2). J Biol Chem (2015) ncbi
mouse monoclonal (HI9a)
  • immunocytochemistry; human; 25 ug/ml
In order to determine the role of CD9 in adhesion, migration and invasiveness of breast cancer cells, BioLegend CD9 antibody (BioLegend, HI9a) was used in immunocytochemistry on human samples at 25 ug/ml. Oncotarget (2015) ncbi
mouse monoclonal (HI9a)
  • flow cytometry; human; fig 4
BioLegend CD9 antibody (BD biosciences, 312104) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (HI9a)
  • flow cytometry; human
  • western blot; human
BioLegend CD9 antibody (BioLegend, HI9a) was used in flow cytometry on human samples and in western blot on human samples . Exp Mol Med (2014) ncbi
Invitrogen
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig s1
In order to elucidate the role of CD151-alpha3beta1 integrin complexes in its cooperation with EGFR to drive tumor cell motility and invasion and as prognositic markers of glioblastoma, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig s1). Oncotarget (2015) ncbi
mouse monoclonal (MM2/57)
  • western blot; mouse; fig 1
In order to identify agents that increase the levels of tetraspanins in macrophages, Invitrogen CD9 antibody (Biosource, clone MM2/57) was used in western blot on mouse samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig 6
  • western blot; human; fig 6
In order to investigate the role of CD9 in the cell adhesion-mediated drug resistance mechanism of small cell lung cancer, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig 6) and in western blot on human samples (fig 6). Cancer Res (2010) ncbi
mouse monoclonal (MM2/57)
  • western blot; human; fig 2
In order to elucidate the contribution of DDR1 and type IV collagen to regulation of CD9-cell surface levels and migration of breast cancer cells, Invitrogen CD9 antibody (Biosource, MM2/57) was used in western blot on human samples (fig 2). Eur J Cell Biol (2010) ncbi
mouse monoclonal (MM2/57)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 5
In order to investigate the role of MT1-MMP-tetraspanin complexes in cancer cell invasion and metastasis, Invitrogen CD9 antibody (BioSource, MM2/57) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 5). Mol Biol Cell (2009) ncbi
mouse monoclonal (MM2/57)
  • western blot; human; fig 1
In order to examine the roles of CD9 and CD81 in cell motility and protease production of smoke-treated macrophages, Invitrogen CD9 antibody (BIOSOURCE, MM2/57) was used in western blot on human samples (fig 1). J Biol Chem (2008) ncbi
mouse monoclonal (MM2/57)
  • immunocytochemistry; human; fig 2
In order to determine the contribution of CD151 on breast cancer, Invitrogen CD9 antibody (Biosource, MM2/57) was used in immunocytochemistry on human samples (fig 2). Cancer Res (2008) ncbi
mouse monoclonal (MM2/57)
  • flow cytometry; human; fig 2A
  • immunoprecipitation; human; fig 2B
  • western blot; human; fig 2B
In order to investigate the role of CD9 in small cell lung cancer cells, Invitrogen CD9 antibody (Biosource, MM2/57) was used in flow cytometry on human samples (fig 2A), in immunoprecipitation on human samples (fig 2B) and in western blot on human samples (fig 2B). Cancer Res (2006) ncbi
Bio-Rad
mouse monoclonal (MM2/57)
  • flow cytometry; dogs
Bio-Rad CD9 antibody (Serotec, MCA469F) was used in flow cytometry on dogs samples . Acta Vet Scand (2014) ncbi
Articles Reviewed
  1. Kretschmann S, Herda S, Bruns H, Russ J, van der Meijden E, Schlötzer Schrehardt U, et al. Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY. J Clin Invest. 2019;129:2952-2963 pubmed publisher
  2. Klymiuk M, Balz N, Elashry M, Heimann M, Wenisch S, Arnhold S. Exosomes isolation and identification from equine mesenchymal stem cells. BMC Vet Res. 2019;15:42 pubmed publisher
  3. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  4. Chung H, Calis J, Wu X, Sun T, Yu Y, Sarbanes S, et al. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell. 2018;172:811-824.e14 pubmed publisher
  5. van Herwijnen M, Zonneveld M, Goerdayal S, Nolte t Hoen E, Garssen J, Stahl B, et al. Comprehensive Proteomic Analysis of Human Milk-derived Extracellular Vesicles Unveils a Novel Functional Proteome Distinct from Other Milk Components. Mol Cell Proteomics. 2016;15:3412-3423 pubmed
  6. Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, et al. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget. 2015;6:29675-93 pubmed publisher
  7. Huygens C, Liénart S, Dedobbeleer O, Stockis J, Gauthy E, Coulie P, et al. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells. J Biol Chem. 2015;290:20105-16 pubmed publisher
  8. Rappa G, Green T, Karbanová J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6:7970-91 pubmed
  9. Sharivkin R, Walker M, Soen Y. Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets. PLoS ONE. 2015;10:e0115100 pubmed publisher
  10. Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, et al. Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes. Exp Mol Med. 2014;46:e89 pubmed publisher
  11. Kang M, Park H. Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation. Acta Vet Scand. 2014;56:16 pubmed publisher
  12. Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, et al. Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages. PLoS ONE. 2013;8:e73706 pubmed publisher
  13. Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, et al. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res. 2010;70:8025-35 pubmed publisher
  14. Castro Sanchez L, Soto Guzman A, Navarro Tito N, Martinez Orozco R, Salazar E. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol. 2010;89:843-52 pubmed publisher
  15. Lafleur M, Xu D, Hemler M. Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Mol Biol Cell. 2009;20:2030-40 pubmed publisher
  16. Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, et al. Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem. 2008;283:26089-97 pubmed publisher
  17. Yang X, Richardson A, Torres Arzayus M, Zhou P, Sharma C, Kazarov A, et al. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res. 2008;68:3204-13 pubmed publisher
  18. Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M, et al. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res. 2006;66:9557-65 pubmed